MedPath

Study to know the safety and effectiveness of blood pressure supporting and brain pressure reducing drugs through the smaller peripheral veins

Not Applicable
Completed
Conditions
Health Condition 1: null- Patients more than 18 years of age admitted to ICU requiring single Vasoactive medication or hypertonic saline through Peripheral Intravenous line.
Registration Number
CTRI/2018/05/013964
Lead Sponsor
Bangalore Baptist Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
208
Inclusion Criteria

Patients more than 18 years of age admitted to ICU requiring single vasoactive medications or 3% Saline through Peripheral Intravenous line with either Mean arterial pressure (MAP) < 65 mmHg orSystolic blood pressure (SBP) < 90 mmHg or Cerebral oedema or raised ICP

Exclusion Criteria

Patients already having Central Venous Catheter access.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Effectiveness of peripheral intravenous (PIV) line in administering vasoactive medications and hypertonic saline infusion in critically ill patients.Timepoint: After stopping infusion through the peripheral intravenous line ( It can either be after clinical improvement or death or central venous catheter placement )
Secondary Outcome Measures
NameTimeMethod
Reason for insertion of central venous catheter access <br/ ><br>Total time of infusion to develop extravasation and its association with site and size of peripheral intravenous lineTimepoint: After central venous catheter placement or After development of extravasation needing either change in site of peripheral line or need for central venous access
© Copyright 2025. All Rights Reserved by MedPath